The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours

M. Takemoto, Masahiro Kuroda, M. Urano, Y. Nishimura, S. Kawasaki, H. Kato, Y. Okumura, S. Akaki, Susumu Kanazawa, Jun-Ichi Asaumi, I. Joja, Y. Hiraki

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, the most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests that the drug of choice at elevated temperatures may be different from that at the physiological temperature, and that the alkylating agents may be most effective at elevated temperatures. To further investigate these possibilities, the effect of chemotherapeutic agents were compared. These agents were cyclophosphamide, ifosfamide, melphalan, cisdiamminedichloroplatinum (II), 5-fluorouracil, mitomycin C and bleomycin. Three tumours (mammary carcinoma, osteosarcoma and squamous cell carcinoma) were used. They were transplanted into the feet of C3H/He mice. When tumours reached 65 mm3, a test agent was injected intraperitoneally. Tumours were immediately heated at 41.5°C for 30 min, and the tumour growth (TG) time was studied for each tumour. Using the TG times, the TG-50 (the time required for one-half of the total number of the treated tumours to reach the volume of 800 mm3 from 65 mm3) was calculated. Subsequently, the tumour growth delay time (GDT) and the thermal enhancement ratio (TER) were obtained. The GDT was the difference between the TG-50 of treated tumours and that of non-treated control tumours. The TER was the ratio of the GDT of a group treated with an agent at 41.5°C to that of a group treated with the agent at room temperature. Results showed that the top three effective agents tested at 41.5°C were solely alkylating agents - CY, IFO and L-PAM - for each kind of tumour. A GDT of cisplatin was smaller than those of the alkylating agents. The smallest TER, 1.1, was observed for 5-fluorouracil, which was given for mammary carcinoma, and for mitomycin C, which was given for squamous cell carcinoma. It could be concluded that the alkylating agents at elevated temperatures might be the drugs of choice for many types of tumours. The possible mechanisms of thermal enhancement associated with these agents are discussed.

Original languageEnglish
Pages (from-to)193-203
Number of pages11
JournalInternational Journal of Hyperthermia
Volume19
Issue number2
DOIs
Publication statusPublished - Mar 2003

Fingerprint

Fever
Neoplasms
Alkylating Agents
Growth
Temperature
Hot Temperature
Melphalan
Mitomycin
Fluorouracil
Squamous Cell Carcinoma
Breast Neoplasms
Ifosfamide
Inbred C3H Mouse
Bleomycin
Osteosarcoma
Pharmaceutical Preparations
Cyclophosphamide
Cisplatin
Foot

Keywords

  • Animal tumours
  • Chemotherapy
  • Mild hyperthermia
  • Thermal enhancement
  • Thermochemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Radiological and Ultrasound Technology

Cite this

The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours. / Takemoto, M.; Kuroda, Masahiro; Urano, M.; Nishimura, Y.; Kawasaki, S.; Kato, H.; Okumura, Y.; Akaki, S.; Kanazawa, Susumu; Asaumi, Jun-Ichi; Joja, I.; Hiraki, Y.

In: International Journal of Hyperthermia, Vol. 19, No. 2, 03.2003, p. 193-203.

Research output: Contribution to journalArticle

Takemoto, M. ; Kuroda, Masahiro ; Urano, M. ; Nishimura, Y. ; Kawasaki, S. ; Kato, H. ; Okumura, Y. ; Akaki, S. ; Kanazawa, Susumu ; Asaumi, Jun-Ichi ; Joja, I. ; Hiraki, Y. / The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours. In: International Journal of Hyperthermia. 2003 ; Vol. 19, No. 2. pp. 193-203.
@article{0f81a08fe552442798b5f8d4c555ba72,
title = "The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours",
abstract = "It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, the most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests that the drug of choice at elevated temperatures may be different from that at the physiological temperature, and that the alkylating agents may be most effective at elevated temperatures. To further investigate these possibilities, the effect of chemotherapeutic agents were compared. These agents were cyclophosphamide, ifosfamide, melphalan, cisdiamminedichloroplatinum (II), 5-fluorouracil, mitomycin C and bleomycin. Three tumours (mammary carcinoma, osteosarcoma and squamous cell carcinoma) were used. They were transplanted into the feet of C3H/He mice. When tumours reached 65 mm3, a test agent was injected intraperitoneally. Tumours were immediately heated at 41.5°C for 30 min, and the tumour growth (TG) time was studied for each tumour. Using the TG times, the TG-50 (the time required for one-half of the total number of the treated tumours to reach the volume of 800 mm3 from 65 mm3) was calculated. Subsequently, the tumour growth delay time (GDT) and the thermal enhancement ratio (TER) were obtained. The GDT was the difference between the TG-50 of treated tumours and that of non-treated control tumours. The TER was the ratio of the GDT of a group treated with an agent at 41.5°C to that of a group treated with the agent at room temperature. Results showed that the top three effective agents tested at 41.5°C were solely alkylating agents - CY, IFO and L-PAM - for each kind of tumour. A GDT of cisplatin was smaller than those of the alkylating agents. The smallest TER, 1.1, was observed for 5-fluorouracil, which was given for mammary carcinoma, and for mitomycin C, which was given for squamous cell carcinoma. It could be concluded that the alkylating agents at elevated temperatures might be the drugs of choice for many types of tumours. The possible mechanisms of thermal enhancement associated with these agents are discussed.",
keywords = "Animal tumours, Chemotherapy, Mild hyperthermia, Thermal enhancement, Thermochemotherapy",
author = "M. Takemoto and Masahiro Kuroda and M. Urano and Y. Nishimura and S. Kawasaki and H. Kato and Y. Okumura and S. Akaki and Susumu Kanazawa and Jun-Ichi Asaumi and I. Joja and Y. Hiraki",
year = "2003",
month = "3",
doi = "10.1080/0265673021000035235",
language = "English",
volume = "19",
pages = "193--203",
journal = "International Journal of Hyperthermia",
issn = "0265-6736",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours

AU - Takemoto, M.

AU - Kuroda, Masahiro

AU - Urano, M.

AU - Nishimura, Y.

AU - Kawasaki, S.

AU - Kato, H.

AU - Okumura, Y.

AU - Akaki, S.

AU - Kanazawa, Susumu

AU - Asaumi, Jun-Ichi

AU - Joja, I.

AU - Hiraki, Y.

PY - 2003/3

Y1 - 2003/3

N2 - It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, the most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests that the drug of choice at elevated temperatures may be different from that at the physiological temperature, and that the alkylating agents may be most effective at elevated temperatures. To further investigate these possibilities, the effect of chemotherapeutic agents were compared. These agents were cyclophosphamide, ifosfamide, melphalan, cisdiamminedichloroplatinum (II), 5-fluorouracil, mitomycin C and bleomycin. Three tumours (mammary carcinoma, osteosarcoma and squamous cell carcinoma) were used. They were transplanted into the feet of C3H/He mice. When tumours reached 65 mm3, a test agent was injected intraperitoneally. Tumours were immediately heated at 41.5°C for 30 min, and the tumour growth (TG) time was studied for each tumour. Using the TG times, the TG-50 (the time required for one-half of the total number of the treated tumours to reach the volume of 800 mm3 from 65 mm3) was calculated. Subsequently, the tumour growth delay time (GDT) and the thermal enhancement ratio (TER) were obtained. The GDT was the difference between the TG-50 of treated tumours and that of non-treated control tumours. The TER was the ratio of the GDT of a group treated with an agent at 41.5°C to that of a group treated with the agent at room temperature. Results showed that the top three effective agents tested at 41.5°C were solely alkylating agents - CY, IFO and L-PAM - for each kind of tumour. A GDT of cisplatin was smaller than those of the alkylating agents. The smallest TER, 1.1, was observed for 5-fluorouracil, which was given for mammary carcinoma, and for mitomycin C, which was given for squamous cell carcinoma. It could be concluded that the alkylating agents at elevated temperatures might be the drugs of choice for many types of tumours. The possible mechanisms of thermal enhancement associated with these agents are discussed.

AB - It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, the most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests that the drug of choice at elevated temperatures may be different from that at the physiological temperature, and that the alkylating agents may be most effective at elevated temperatures. To further investigate these possibilities, the effect of chemotherapeutic agents were compared. These agents were cyclophosphamide, ifosfamide, melphalan, cisdiamminedichloroplatinum (II), 5-fluorouracil, mitomycin C and bleomycin. Three tumours (mammary carcinoma, osteosarcoma and squamous cell carcinoma) were used. They were transplanted into the feet of C3H/He mice. When tumours reached 65 mm3, a test agent was injected intraperitoneally. Tumours were immediately heated at 41.5°C for 30 min, and the tumour growth (TG) time was studied for each tumour. Using the TG times, the TG-50 (the time required for one-half of the total number of the treated tumours to reach the volume of 800 mm3 from 65 mm3) was calculated. Subsequently, the tumour growth delay time (GDT) and the thermal enhancement ratio (TER) were obtained. The GDT was the difference between the TG-50 of treated tumours and that of non-treated control tumours. The TER was the ratio of the GDT of a group treated with an agent at 41.5°C to that of a group treated with the agent at room temperature. Results showed that the top three effective agents tested at 41.5°C were solely alkylating agents - CY, IFO and L-PAM - for each kind of tumour. A GDT of cisplatin was smaller than those of the alkylating agents. The smallest TER, 1.1, was observed for 5-fluorouracil, which was given for mammary carcinoma, and for mitomycin C, which was given for squamous cell carcinoma. It could be concluded that the alkylating agents at elevated temperatures might be the drugs of choice for many types of tumours. The possible mechanisms of thermal enhancement associated with these agents are discussed.

KW - Animal tumours

KW - Chemotherapy

KW - Mild hyperthermia

KW - Thermal enhancement

KW - Thermochemotherapy

UR - http://www.scopus.com/inward/record.url?scp=0037335525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037335525&partnerID=8YFLogxK

U2 - 10.1080/0265673021000035235

DO - 10.1080/0265673021000035235

M3 - Article

C2 - 12623641

AN - SCOPUS:0037335525

VL - 19

SP - 193

EP - 203

JO - International Journal of Hyperthermia

JF - International Journal of Hyperthermia

SN - 0265-6736

IS - 2

ER -